Murat Koçer

492 total citations
33 papers, 250 citations indexed

About

Murat Koçer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Murat Koçer has authored 33 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Murat Koçer's work include Colorectal Cancer Screening and Detection (3 papers), Blood groups and transfusion (3 papers) and Fibroblast Growth Factor Research (2 papers). Murat Koçer is often cited by papers focused on Colorectal Cancer Screening and Detection (3 papers), Blood groups and transfusion (3 papers) and Fibroblast Growth Factor Research (2 papers). Murat Koçer collaborates with scholars based in Türkiye, Kazakhstan and Germany. Murat Koçer's co-authors include Mustafa Nazıroğlu, Ülkü Yalçıntaş Arslan, Tolga Taha Sönmez, Mehmet Artaç, Nazım Serdar Turhal, Bülent Karabulut, Şirin Başpınar, Nilgün Kapucuoğlu, Şeyda Gündüz and Hakan Bozcuk and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Murat Koçer

28 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murat Koçer Türkiye 11 148 74 40 40 32 33 250
Karlijn L. van Rooijen Netherlands 6 142 1.0× 75 1.0× 31 0.8× 55 1.4× 38 1.2× 10 247
Utku Oflazoğlu Türkiye 11 154 1.0× 44 0.6× 58 1.4× 45 1.1× 41 1.3× 41 312
Tomoyo Oguri Japan 11 183 1.2× 173 2.3× 63 1.6× 39 1.0× 34 1.1× 28 321
Michel Gatineau France 8 174 1.2× 60 0.8× 102 2.5× 21 0.5× 25 0.8× 21 275
Mario Nicolini Italy 10 134 0.9× 115 1.6× 52 1.3× 37 0.9× 19 0.6× 20 277
Shuling Han China 8 183 1.2× 48 0.6× 98 2.5× 52 1.3× 50 1.6× 28 346
Shu-Kui Qin China 5 179 1.2× 129 1.7× 38 0.9× 23 0.6× 48 1.5× 11 270
Mitsuru Yanagaki Japan 11 143 1.0× 56 0.8× 34 0.8× 32 0.8× 86 2.7× 48 261
Shinsuke Kurokawa Japan 8 104 0.7× 110 1.5× 70 1.8× 35 0.9× 45 1.4× 32 245
Laura Mastrangelo Italy 6 99 0.7× 71 1.0× 97 2.4× 62 1.6× 58 1.8× 10 297

Countries citing papers authored by Murat Koçer

Since Specialization
Citations

This map shows the geographic impact of Murat Koçer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Koçer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Koçer more than expected).

Fields of papers citing papers by Murat Koçer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Koçer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Koçer. The network helps show where Murat Koçer may publish in the future.

Co-authorship network of co-authors of Murat Koçer

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Koçer. A scholar is included among the top collaborators of Murat Koçer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Koçer. Murat Koçer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koçer, Murat, et al.. (2024). Rectal Cancer in Young Adults: A Single Center Experience. Journal of Adolescent and Young Adult Oncology. 14(4). 319–327.
2.
Bozcuk, Hakan, Hasan Şenol Çoşkun, Sema Sezgin Göksu, et al.. (2021). Prospective external validation of an updated algorithm to quantify risk of febrile neutropenia in cancer patients after a cycle of chemotherapy. Supportive Care in Cancer. 30(3). 2621–2629. 2 indexed citations
3.
Önal, Özgür, et al.. (2020). Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(8). 1838–1850. 13 indexed citations
4.
Önal, Özgür, et al.. (2020). Survival analysis and factors affecting survival in patients with pancreatic cancer.. Medical Science and Discovery. 7(2). 412–418. 1 indexed citations
5.
Gömceli, İsmail, et al.. (2019). Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals. The Turkish Journal of Gastroenterology. 30(10). 910–916. 3 indexed citations
6.
Özaslan, Ersin, Metin Özkan, İrfan Çiçin, et al.. (2018). Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA). Clinical and Applied Thrombosis/Hemostasis. 24(6). 973–979. 2 indexed citations
7.
Artaç, Mehmet, Hasan Şenol Çoşkun, Levent Korkmaz, et al.. (2016). Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study. Clinical Genitourinary Cancer. 14(4). e347–e353. 4 indexed citations
8.
Koşar, Pınar Aslan, et al.. (2016). Cytogenetic findings in patients diagnosed with breast cancer having undergone adjuvant chemotherapy regimens. Genetics and Molecular Research. 15(1).
9.
Bozcuk, Hakan, Burcu Çakar, Şeyda Gündüz, et al.. (2015). Factors predicting lapatinib efficacy in HER-2+ metastatic breast carcinoma: Does it work better in different histologic subtypes?. Indian Journal of Cancer. 52(4). 517–517. 4 indexed citations
10.
Kapucuoğlu, Nilgün, et al.. (2015). The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast. Pathology - Research and Practice. 211(10). 740–747. 26 indexed citations
11.
Artaç, Mehmet, Nazım Serdar Turhal, Murat Koçer, et al.. (2014). Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study. Tumori Journal. 100(2). 143–148. 16 indexed citations
12.
Artaç, Mehmet, Nazım Serdar Turhal, Murat Koçer, et al.. (2014). Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.. PubMed. 100(2). 143–8. 18 indexed citations
14.
Can, Alper, Erkan Doğan, İbrahim Vedat Bayoğlu, et al.. (2014). Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey. Asian Pacific Journal of Cancer Prevention. 15(6). 2923–2927. 20 indexed citations
15.
Bozcuk, Hakan, Mustafa Yıldız, Mehmet Artaç, et al.. (2014). A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study. Supportive Care in Cancer. 23(6). 1759–1767. 12 indexed citations
16.
Nazıroğlu, Mustafa, et al.. (2013). Basic Fibroblast Growth Factor Attenuates Bisphosphonate-Induced Oxidative Injury but Decreases Zinc and Copper Levels in Oral Epithelium of Rat. Biological Trace Element Research. 153(1-3). 251–256. 21 indexed citations
17.
Koçer, Murat, et al.. (2013). Effects of Bisphosphonate on Oxidative Stress Levels in Patients With Different Types of Cancer. Cancer Investigation. 32(2). 37–42. 8 indexed citations
18.
Utkan, Güngör, Kadri Altundağ, Osman Şevki Arslan, et al.. (2012). ABO and Rh blood groups frequency in women with HER2 positive breast cancer.. PubMed. 17(3). 457–60. 6 indexed citations
19.
Koçer, Murat, et al.. (2011). Acute transient encephalopathy after weekly paclitaxel infusion. Medical Oncology. 29(2). 1297–1299. 10 indexed citations
20.
Alkış, Necati, et al.. (2010). Primary adult soft tissue sarcomas: analysis of 294 patients. Medical Oncology. 28(1). 391–396. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026